-
公开(公告)号:EP2264038B1
公开(公告)日:2016-01-06
申请号:EP09730232.7
申请日:2009-04-08
发明人: KUBOTA, Yasushi , INOUE, Tsutomu
IPC分类号: C07D491/16 , C07D317/60 , C07D491/06 , C07D491/20
CPC分类号: C07D317/60 , C07D491/06 , C07D491/16 , C07D491/20
-
12.INHIBITORS OF VIRAL REPLICATION, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTICAL USES 审中-公开
标题翻译: 病毒复制抑制剂,工艺及其使用及其治疗公开(公告)号:EP2903983A1
公开(公告)日:2015-08-12
申请号:EP13773761.5
申请日:2013-10-07
申请人: LABORATOIRE BIODIM
发明人: BENAROUS, Richard , CHEVREUIL, Francis , LEDOUSSAL, Benoit , CHASSET, Sophie , LE STRAT, Frédéric
IPC分类号: C07D409/04 , C07D409/14 , C07D491/04 , A61K31/381 , A61P31/18 , C07D333/24 , C07D417/04 , C07D491/052 , C07D491/06
CPC分类号: C07D333/24 , A61K31/381 , A61K31/4155 , A61K31/427 , A61K31/436 , A61K31/4436 , A61K31/4709 , A61K31/506 , A61K45/06 , C07D409/04 , C07D409/14 , C07D417/04 , C07D491/04 , C07D491/052 , C07D491/06
摘要: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
-
公开(公告)号:EP2149560B1
公开(公告)日:2015-05-13
申请号:EP08764424.1
申请日:2008-05-20
申请人: Astellas Pharma Inc.
发明人: SHISHIKURA, Jun-ichi , INOUE, Makoto , OGIYAMA, Takashi , YONEZAWA, Koichi , YAMAKI, Susumu , YOKOYAMA, Kazuhiro , KAKIMOTO, Shuichirou , OKADA, Hidetsugu
IPC分类号: C07D217/04 , A61K31/4355 , A61K31/472 , A61K31/4725 , A61K31/4747 , A61K31/496 , A61P1/00 , A61P9/00 , A61P13/10 , A61P25/04 , A61P25/06 , A61P25/10 , A61P25/22 , A61P25/24 , A61P43/00 , C07D217/14 , C07D217/16 , C07D221/20 , C07D401/04 , C07D401/06 , C07D401/12
CPC分类号: C07D217/04 , C07D217/14 , C07D217/16 , C07D221/20 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/06 , C07D491/06
-
公开(公告)号:EP2694160A1
公开(公告)日:2014-02-12
申请号:EP12715787.3
申请日:2012-04-03
发明人: LI, Zheng, Jane , LI, Zhibin , LUO, Laibin , OFFERDAHL, Thomas , KIM, Soojin , YANG, Bing-shiou
IPC分类号: A61P31/18 , A61K31/435 , C07D491/06
CPC分类号: A61K31/436 , A61K31/435 , A61K45/06 , C07D491/06
摘要: The invention relates to novel crystalline forms of (2S)-2-tert-butoxy-2-(4-(2,3- dihydropyrano[4,3,2-de]quinolin-7-yl)-2-methylquinolin-3-yl)acetic acid, the hydrochloride salt thereof, novel crystalline forms of the hydrochloride salt, methods for the preparation thereof, pharmaceutical compositions thereof and their use in the treatment of Human Immunodeficiency Virus (HIV) infection.
-
公开(公告)号:EP2510949A4
公开(公告)日:2013-11-13
申请号:EP10836055
申请日:2010-12-10
申请人: ASTELLAS PHARMA INC
IPC分类号: A61K45/00 , A61K31/137 , A61K31/335 , A61K31/343 , A61K31/353 , A61K31/397 , A61K31/4025 , A61K31/4035 , A61K31/407 , A61K31/415
CPC分类号: C07D491/04 , A61K31/00 , A61K31/137 , A61K31/335 , A61K31/343 , A61K31/353 , A61K31/397 , A61K31/4025 , A61K31/4035 , A61K31/407 , A61K31/415 , A61K31/416 , A61K31/4162 , A61K31/437 , A61K31/4525 , A61K31/4535 , A61K31/473 , A61K31/495 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/5365 , A61K31/5375 , A61K31/55 , A61K31/551 , C07D209/14 , C07D209/52 , C07D213/74 , C07D223/04 , C07D231/56 , C07D239/70 , C07D307/81 , C07D311/04 , C07D471/04 , C07D471/06 , C07D487/04 , C07D491/06 , C07D495/04 , C07D513/06
-
公开(公告)号:EP2640705A2
公开(公告)日:2013-09-25
申请号:EP11781819.5
申请日:2011-11-15
发明人: CHALTIN, Patrick , CHRIST, Frauke , DEBYSER, Zeger , DE MAEYER, Marc , MARCHAND, Arnaud , MARCHAND, Damien , VOET, Arnout
IPC分类号: C07D221/06 , C07D221/08 , C07D221/10 , C07D401/04 , C07D417/04 , C07D471/04 , C07D471/14 , C07D487/04 , C07D491/048 , C07D491/06 , C07D495/04 , C07D495/14 , C07D519/00 , A61P31/00 , A61K31/435 , A61K31/4355 , A61K31/437 , A61K31/519
CPC分类号: A61K31/519 , A61K31/437 , A61K31/473 , A61K45/06 , C07D221/06 , C07D221/08 , C07D221/10 , C07D221/16 , C07D401/04 , C07D417/04 , C07D471/04 , C07D471/14 , C07D487/04 , C07D487/14 , C07D491/048 , C07D491/06 , C07D491/16 , C07D495/04 , C07D495/14 , C07D519/00 , A61K2300/00
摘要: The present invention relates to compounds of formula (A), as further defined herein, having antiviral activity, more specifically HIV (Human Immunodeficiency Virus) replication inhibiting 5 properties. The invention also relates to pharmaceutical compositions comprising an effective amount of such compounds as active ingredients. The invention further relates to the use of such compounds, optionally combined with one or more other drugs having antiviral activity, for the treatment of animals suffering from viral infections, in particular HIV infection.
摘要翻译: 本发明涉及如本文进一步定义的式(A)化合物,其具有抗病毒活性,更具体地说是HIV(人类免疫缺陷病毒)复制抑制性质。 本发明还涉及包含有效量的这种化合物作为活性成分的药物组合物。 本发明进一步涉及这种化合物的用途,其任选地与一种或多种具有抗病毒活性的其它药物组合用于治疗患有病毒感染,特别是HIV感染的动物。
-
公开(公告)号:EP2632444A1
公开(公告)日:2013-09-04
申请号:EP11776146.0
申请日:2011-10-24
申请人: Université d'Aix-Marseille , INSERM (Institut National de la Santé et de la Recherche Médicale) , Institut Curie , Centre national de la recherche scientifique
IPC分类号: A61K31/00 , A61K31/145 , A61K31/436 , A61K38/00 , A61K38/13 , A61P43/00 , A61P25/00
CPC分类号: A61K31/145 , A61K31/00 , A61K31/436 , A61K38/13 , A61K45/06 , C07C323/25 , C07D491/06 , C07K7/645
摘要: The invention relates to the use of cystamine, cysteamine, or a salt thereof, or of calcineurin inhibitors for treating a MeCP2-associated disorder such as Rett syndrome.
-
公开(公告)号:EP2510949A1
公开(公告)日:2012-10-17
申请号:EP10836055.3
申请日:2010-12-10
申请人: Astellas Pharma Inc.
IPC分类号: A61K45/00 , A61K31/137 , A61K31/335 , A61K31/343 , A61K31/353 , A61K31/397 , A61K31/4025 , A61K31/4035 , A61K31/407 , A61K31/415
CPC分类号: C07D491/04 , A61K31/00 , A61K31/137 , A61K31/335 , A61K31/343 , A61K31/353 , A61K31/397 , A61K31/4025 , A61K31/4035 , A61K31/407 , A61K31/415 , A61K31/416 , A61K31/4162 , A61K31/437 , A61K31/4525 , A61K31/4535 , A61K31/473 , A61K31/495 , A61K31/496 , A61K31/497 , A61K31/4985 , A61K31/5365 , A61K31/5375 , A61K31/55 , A61K31/551 , C07D209/14 , C07D209/52 , C07D213/74 , C07D223/04 , C07D231/56 , C07D239/70 , C07D307/81 , C07D311/04 , C07D471/04 , C07D471/06 , C07D487/04 , C07D491/06 , C07D495/04 , C07D513/06
摘要: An agent for treating fibromyalgia containing a 5-HT 2C receptor agonist as an active ingredient
摘要翻译: 用于治疗含有5-HT 2C受体激动剂作为活性成分的纤维肌痛的药剂
-
19.SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF 有权
标题翻译: 取代的偶氮蒽衍生物及其药物组合物及其使用方法公开(公告)号:EP2413693A4
公开(公告)日:2012-08-22
申请号:EP10779665
申请日:2010-03-30
申请人: TRANSTECH PHARMA INC
发明人: MJALLI ADNAN M M , BEHME CHRISTOPHER , CHRISTEN DANIEL P , POLISETTI DHARMA RAO , QUADA JAMES , SANTHOSH KALPATHY , BONDLELA MURALIDHAR , GUZEL MUSTAFA , YARRAGUNTA RAVINDRA REDDY , GOHIMUKKULA DEVI REDDY , ANDREWS ROBERT CARL , DAVIS STEPHEN THOMAS , YOKUM THOMAS SCOTT , FREEMAN JENNIFER L R
IPC分类号: A01N35/00 , A61K31/12 , A61P3/10 , C07D491/06
CPC分类号: C07D491/056 , C07D319/20 , C07D491/06
-
公开(公告)号:EP2264038A4
公开(公告)日:2011-06-08
申请号:EP09730232
申请日:2009-04-08
申请人: NIPPON SODA CO
发明人: KUBOTA YASUSHI , INOUE TSUTOMU
IPC分类号: C07D491/16 , C07D317/60 , C07D491/06 , C07D491/20
CPC分类号: C07D317/60 , C07D491/06 , C07D491/16 , C07D491/20
-
-
-
-
-
-
-
-
-